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Abstract
Cancer-associated fibroblasts (CAFs) are key determinants in the malignant progression of cancer, supporting
tumorigenesis and metastasis. CAFs also mediate epithelial mesenchymal transition (EMT) of tumor cells and
their achievement of stem cell traits. We demonstrate that CAFs induce EMT and stemness through a proin-
flammatory signature, which exploits reactive oxygen species to drive a migratory and aggressive phenotype of
prostate carcinoma cells. CAFs exert their propelling role for EMT in strict dependence on cycloxygenase-2
(COX-2), nuclear factor-jB, and hypoxia-inducible factor-1. CAF-secreted metalloproteases elicit in carcinoma
cells a Rac1b/COX-2-mediated release of reactive oxygen species, which is mandatory for EMT, stemness, and
dissemination of metastatic cells. Tumor growth is abolished, and metastasis formation is severely impaired by
RNA interfering-mediated targeting of the proinflammatory signature, thereby supporting the therapeutic tar-
geting of the circuitry COX-2/nuclear factor-jB /hypoxia-inducible factor-1 as a valuable antimetastatic tool
affecting cancer cell malignancy. Antioxid. Redox Signal. 14, 2361–2371.
Introduction
Although tumorigenesis is largely acknowledged as acell-autonomous process involving genetically trans-
formed cancer cells, the importance of stromal cell types
populating the tumoral microenvironment is now well es-
tablished (4, 41). Reactive stroma is composed by several
heterotypic cells, including cancer associated fibroblasts
(CAFs), macrophages, and endothelial cells. CAFs are phe-
notypically and functionally distinguishable from their nor-
mal counterparts for their augmented proliferation and
differential expression of extracellular matrix (ECM) proteins
and soluble factors (21). Conversely to resting fibroblasts,
CAFs acquire an activated phenotype and can be recognized
by their expression of fibroblast-specific protein 1, desmin,
vimentin, and a-smooth-muscle actin. To date, fibroblasts in
tumor tissues are recognized as a diverse population of
myofibroblastic cells intermixed with other fibroblasts that do
not express a-smooth-muscle actin, although they exert tumor
promoting activity (12, 17, 26, 39).
CAFs communicate among themselves as well as with
cancer cells and inflammatory and immune cells directly
through cell contact and indirectly through paracrine/exo-
crine signaling, proteases, and modulation of ECM. This
complex communications network is pivotal to providing the
appropriate microenvironment to support tumorigenesis,
angiogenesis, and metastasis. Normal fibroblasts play a
helpful role in maintaining epithelial homeostasis by sup-
pressing proliferation of adjacent epithelia (2, 3, 43). After
epithelial neoplastic transformation, CAFs undergo profound
changes, promote tumor growth, induce angiogenesis, and
recruit bone marrow–derived endothelial progenitor cells (1,
30, 31). Interestingly, CAFs can even mediate resistance to
antiangiogenic therapy (11). In addition, CAFs act on motility
of cancer cells through remodeling the ECM (35) and inducing
epithelial mesenchymal transition (EMT) of adiacent carci-
noma cells (17). EMT is an epigenetic transcriptional program
by which epithelial cells gain mesenchymal features as re-
duced cell-cell contact and increased motility, thereby escap-
ing the primary tumor and allowing dissemination of
metastases at a distance (15, 40). A hallmark of EMT is the loss
of E-cadherin expression, correlated with the tumor grade and
stage (9, 10, 14). Several transcription factors have been im-
plicated in the control of EMT, including Snail, Slug, Twist,
Goosecoid, ZEB1, and SIP1 (29).
Conversely to embryonic EMT, EMT serving tissue repair
or metastatic dissemination is often correlated with tissue
inflammation and persists until the provoking spur/injury is
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removed. In keeping, treatment of mammary carcinoma cells
with tumor necrosis factor-a leads to stabilization of Snail
through activation of nuclear factor-jB (NF-jB) pathway (46).
As in developing tumors, CAFs have been shown to orches-
trate macrophage recruitment and neovascularization in strict
dependence on NF-jB (13). We reasoned that CAFs may exert
their propelling role for EMT by eliciting proinflammatory
pathways in metastatic cells. We, therefore, examined the role
of proinflammatory, pro-oxidant, and promigratory path-
ways elicited in EMT undergoing prostate carcinoma (PCa)
cells due to CAF exposure.
Materials and Methods
Materials
Unless specified, all reagents were obtained from Sigma.
All antibodies were from Santa Cruz Biotechnology, except
for anti-hypoxia inducible factor-1a (HIF-1a) and Rac1 (BD
Biosciences), anti-Rac1b (Millipore), and FITC conjugated
anti-CD133 antibodies (Abcam). The FITC mouse anti human
CD44 (clone G44-26) and PE mouse anti human CD24 (clone
ML5) antibodies were from BD Bioscience. shRNA against
cycloxygenase-2 (COX-2), HIF-1a, NF-jB, and negative con-
trol shRNA were from Santa Cruz Biotechnology. 2¢,7¢-
dihydrochlorofluorescein diacetate (H2DCF-DA) was from
Molecular Probes. Ilomastat and Rac1 inhibitor were from
Calbiochem. Tumor growth factor b1 (TGFb1) and interleukin-6
(IL-6) were from PeproTech.
Cell culture and transfections
PC3 cells were obtained from European Collection of Cell
Cultures. Human prostate fibroblasts (HPFs) and CAFs were
isolated from surgical explantation from patients affected by
benign prostatic hyperplasia (HPFs) or from cancer regions of
patients bearing PCa (Gleason 4+ 5) (CAFs) (17). Four dif-
ferent surgical explantations were used for both CAFs and
HPFs, and their ability to induce EMT resulted comparable.
All the isolated human prostate primary fibroblasts, as well as
the other unique renewable resources used in this article, will
be available on request for the scientific community. PC3 cells
and fibroblasts were grown in Dulbecco’s Modified Eagle
Medium containing 10% fetal bovine serum, 10U/ml peni-
cillin, and 10mg/ml streptomycin. CAFs andHPFs have been
used for 15 passages without significant modification of their
ability to elicit EMT.
For fibroblast activation, cells were grown to sub-confluence
and treated for 24h with 10ng/ml TGF-b1 or 50ng/ml IL-6.
Fresh serum-free medium was added for an additional 24 h
before collection of conditioned medium (CM), in order to
obtain CM free from TGF-b1 or IL-6 (but conditioned by their
earlier administration). PC3 cells were then incubated with the
obtained CM for 72h and then used for different analyses.
Transient transfection with p[NF-jB]Luc was performed
with Lipofectamine (Invitrogen), following manufacturer’s
instructions, and its efficiency has been evaluated to 60%
using a co-transfection with pEGFP-N1 (ratio pEGFP-N1/
p[NF-jB]Luc 1:10). Silencing with shRNA was performed
with Lipofectamine (Invitrogen) following manufacturer’s
instructions. Silenced cells were selected by puromycin
treatment, and a pool of stably transfected cells was generated
in order to avoid clonal selection.
Western blot analysis
PC3 cells (1 · 106) were lysed for 20min on ice in 500ll
RIPA lysis buffer (50mM Tris-HCl, pH 7.5, 150mMNaCl, 1%
Triton X-100, 2mM EGTA, 1mM sodium orthovanadate,
1mM phenylmethanesulphonyl-fluoride, 10lg/ml aprotinin,
and 10lg/ml leupeptin). 20lg of total proteins were loaded
on sodium dodecyl sulfate-polyacrylamide gel electrophore-
sis, separated, and transferred onto nitrocellulose. The im-
munoblots were incubated in 3% bovine serum albumin,
10mM Tris-HCl (pH 7.5), 1mM EDTA, and 0.1% Tween 20 for
1 h at room temperature; probed first with specific antibodies
and then with secondary antibodies.
NF-kB activity assay
About 1· 106 PC3 cells were transiently transfected with
2 lg of the luciferase reporter plasmid p[NF-jB]Luc, kept in
growth medium for 24 h, and then exposed to fibroblast CM.
Determination of luciferase activities was performed using
the Luciferase Assay System (Promega), following the man-
ufacturer’s instructions.
In vitro Boyden invasion assay
Transwells (Corning), equipped with an 8-lm-pore poly-
vinylpyrrolidone-free polycarbonate filters, were coated with
50 lg/cm2 of reconstituted Matrigel. About 5· 104 PC3 cells
were loaded into the upper compartment in serum-free
growth medium. Cells were allowed to migrate toward
complete growth medium. After 24 h of incubation at 37C,
non invading cells were removed mechanically using cot-
ton swabs, and the membrane was stained with DiffQuick
solution.
Assay of intracellular reactive oxygen species
Intracellular production ofH2O2was assayed as previously
described (8). Five minutes before the end of the incubation
time, cells were treated with 5lg/ml H2DCF-DA. After
phosphate-buffered saline washing, cells were lysed in 1ml of
RIPA buffer and analyzed immediately by fluorimetric anal-
ysis at 510 nm. Data have been normalized to total protein
content.
Prostaspheres formation and clonogenicity assay
PC3 cells were incubated for 72 h with CM and then de-
tached usingAccutase (Sigma). Single PC3 cells were plated at
150 cells/cm2 on low attachment 100mm plate in Dulbecco’s
modified Eagle’s medium/F12 supplemented with B27 and
N2 media, 5lg/ml insulin, 20 ng/ml fibroblast GF-2, and
20 ng/ml epidermal GF. PC3 cells were grown under these
conditions for 15-20 days and formed non-adherent P0
spheres termed prostaspheres. For the evaluation of self-
renewal, a single prostasphere was dissociated in single cells
with Accutase, and a diluition of one cell per well into 96-well
low attachment plates was performed in order to isolate in-
dividual P1 prostaspheres. Single-cell cloning was confirmed
by microscopic analysis, and single clones were counted.
Flow cytometry
1 · 106 PC3 cells were labeled with FITC-anti-CD44 (clone
G44-26) and PE-anti-CD24 (clone ML5) antibodies for 1h at
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4C in the dark. Cells were washed, and flow cytometry was
performed using an FACSscan (BD Biosciences).
Rac1 activity assay
To quantify the amount of Rac1/Rac1b-GTP, 1· 106 PC3
cells were lysed in RIPA buffer, and the lysates were incu-
bated with 10lg of p21 activated kinase-GST fusion protein,
absorbed on glutathione-Sepharose beads for 1 h at 4C. Im-
munoreactive Rac1 and Rac1b were then quantified by Wes-
tern blot analysis. Lysates were normalized for Rac1 and
Rac1b content by immunoblotting.
Xenograft experiments
In vivo experiments were carried out in accordance with
national guidelines and approved by the ethical committee of
Animal Welfare Office of Italian Work Ministry and conform
to the legal mandates and Italian guidelines for the care and
maintenance of laboratory animals. Six- to 8-week-old male
(six per group) SCID-bg/bg mice (Charles River Laboratories
International) were injected subcutaneously with 1 · 106
PC3 cells or with 1· 106 PC3 cells plus 0.5 · 106 fibroblasts, as
described in (17).
Lung colonization assays
Six- to 8-week old female SCID-bg/bg mice were injected
with PC3 cells treated for 72 h with CM from CAFs or with
serum-free medium as a control. Mice (six animals per group)
were injected into the lateral tail veinswith differently treated-
PC3 cells (1 · 106 in 0.2ml of phosphate-buffered saline). They
were monitored every 3 days and sacrificed after 8 weeks.
Lungs were inspected for metastatic nodules by histological
analyses.
Statistical analysis
Data are presented as means – standard deviation from at
least three independent experiments. Statistical analysis of the
data was performed by Student’s t-test. p-Valuesp0.05 were
considered statistically significant.
Results
CAFs activates a proinflammatory response to elicit
EMT in PC3 cells
To assess the role of proinflammatoty signals elicited by
CAFs in EMT undergoing cells, we used PC3 cells, a line iso-
lated from a bone metastasis of human PCa, and CAFs or
in vitro activated HPFs. HPFs were isolated from prostate
from patients affected by benign prostatic hyperplasia,
whereas CAFs were obtained from the surgically explanted
prostate of patients bearing PCa (Gleason 4 + 5). Expression of
E-cadherin and cytokeratin was performed to exclude epi-
thelial contamination of both CAFs and HPFs. We have al-
ready reported that CAFs and HPFs activated in vitro with
TGFb1 or IL-6 elicits a clear EMT in PC3 cells (17).
In order to study the molecular pathways driving CAF-
induced EMT response in PC3 cells, we analyze the proin-
flammatory pathways in PC3 cells treated with CM from
CAFs or from HPFs activated with TGFb1 or IL-6. PC3 cells
respond to CAF-induced EMT with activation of the NF-jB/
COX-2 pathway, showing similar responses to CAFs or
in vitro activated HPFs (Fig. 1A). In addition, CAF exposure
leads to activation of HIF-1 (Fig. 1A), a known transcription
factor normally engaged by hypoxia but already reported to
be activated in normoxia by inflammation in a COX-2-
dependent manner (38). Silencing of NF-jB, COX-2, and
HIF-1 by shRNA in PC3 cells after exposure to CAFs or in vitro
activated HPFs reveals that this proinflammatory axis plays a
mandatory role in orchestrating CAF-induced EMT in PC3
cells. Indeed, silencing of each COX-2, NF-jB, and HIF-1 is
able to block invasiveness and expression of EMT markers
(Snail, Twist, Met, E-Cad) (Fig. 1B, C and Supplementary Fig.
S1; Supplementary Data are available online at www
.liebertonline.com/ars).
We have already correlated CAF-induced EMT with
achievement of stem cell traits in PC3 cells, reporting in-
creased expression of CD133 and CD44/CD24 ratio, P1
prostasphere formation, and tumor initiating cells in SCID
mice xenografts (17). To validate our data on the proin-
flammatory response elicited by CAFs on PC3 cells, we ana-
lyzed expression of stem cell markers and anchorage
independence growth of PC3 cells silenced for NF-jB, COX-2,
and HIF-1. In keeping with the idea that stemness of PC3 cells
is intimately linked to activation of their EMT after exposure
to CAFs, silencing of NF-jB, COX-2, or HIF-1 blocks the in-
crease in CD133 or CD44/CD24 expression and P1 prosta-
sphere formation (Fig. 1D–F).
PCa cells activate reactive oxygen
species production on CAF exposure
Inflammation and oxidative stress have already been
linked to cancer progression and claimed as responsible for
enhanced malignancy (25, 32). Oxidative stress, due to de-
regulated intracellular reactive oxygen species (ROS) pro-
duction, has been correlated to PCa carcinogenesis, androgen
resistance, anchorage independence, and resistance to anoikis
(18, 22). We observed that exposure to CAFs, or in vitro acti-
vatedHPFs, leads to enhancement of ROS content of PC3 cells
(Fig. 2A). ROS delivery appears to be mainly due to arachi-
donic acid metabolism deregulation, as indicated by the
ability of COX-2 inhibitors to block CAF-induced ROS gen-
eration and the invasive phenotype (Fig. 2A, B and Supple-
mentary Fig. S2). In keeping, silencing of COX-2 is able to
dramatically reduce CAF-mediated ROS production (Fig. 2C).
EMT has already been correlated with oxidative stress in
mouse breast carcinoma cells, a mandatory event for carcino-
genesis due to DNA oxidative damage. In this model, EMT has
been elicited by treatment with soluble metalloprotease-3
(MMP-3), and ROS production is due to activation of Rac1b, an
alternatively spliced isoform of Rac1 (36). We observed that
treatment of CAFs with the MMP broad range inhibitor ilo-
mastat severely decreases COX-2, HIF-1, and NF-jB activation
in PC3 cells (Fig. 3A) as well as ROS production and EMT (Fig.
3B, C) due to exposure to CAFs or to HPFs activated in vitro by
IL-6. In addition, we observed a clear activation of Rac1 and a
de novo expression of Rac1b isoform (Fig. 3D, E). In keeping
with the reported constitutive activation of Rac1b on its tran-
scriptional activation (33), we detect a clear linearity between
expression and activity of Rac1b isoform (Fig. 3E). Finally, the
role of Rac1 activation in eliciting a proinflammatory response
in PC3 cells is stressed by the ability of Rac-1 inhibitor to
downregulate theNF-jB, COX-2, andHIF-1 pathway (Fig. 3F).
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CAF-mediated ROS production in PC3 cells
is mandatory for EMT and stemness
COX-2-mediated ROS mainly affects the pre-malignant
condition and carcinogenesis of high-grade prostate in-
traepithelial neoplasia, but its role in tumor progression is
unknown (34). We, therefore, analyzed the role of ROS pro-
duced on CAF exposure, mainly due to COX-2 activation, in
EMT and invasiveness. We used both N-acetyl-cysteine
(NAC) or permeable-catalase treatments and observed an
FIG. 1. CAFs promote EMT
and stemness by triggering a
proinflammatory pathway.
(A) PC3 cells were incubated
with the indicated CM and the
levels of COX-2, HIF-1a, and
IkBa were assessed by immu-
noblotting. NF-jB activity was
also evaluated by a luciferase
assay. *p< 0.001 versus St Med.
(B) PC3 cells stably silenced
with shRNA for COX-2, HIF-
1a, and NF-jB were treated as
in A, and their invasion was
evaluated. Invading cells were
counted and a bar graph, rep-
resentative of six randomly
chosen fields, is shown.
*p< 0.005 versus Control,
HPFs+TGFb1, HPFs+ IL-6,
and CAFs, respectively. (C)
PC3 cells were stimulated with
CM as in A, and the expression
of EMT markers was analyzed
by immunoblotting. (D, E)
PC3 cells, silenced as in B, were
stimulated with CM from
CAFs, and the percentage of
CD133 positive cells (D) and
CD44high/CD24low cells (E)
was analyzed by means of
FACS analysis. *p < 0.001 ver-
sus Control+CAF. (F) Cells,
silenced as in B, were treated
as in D, and P1 individual
spheres derived from PC3 cells
treated as indicated were
counted, photographed, and




tion; CM, conditioned medium;
COX-2, cycloxygenase-2; HIF-
1a, hypoxia inducible factor-1a;
NF-jB, nuclear factor-jB; HPFs,
human prostate fibroblasts;
TGFb1, tumor growth factor-b1;
IL-6, interleukin-6.
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overlapping response: a definite inhibition of the proinvasive
effect elicited by exposure to CAFs or in vitro activated HPFs,
as well as of the relative EMT programme (Fig. 4A, B and
Supplementary Fig. S3A, B). The treatment of EMT under-
going PC3 cells with selective ROS source inhibitors (NDGA
for lypoxigenases, DPI for NADPH oxidase, acetyl-salicilyc
acid for COX-1/2, and nimesulide for COX-2) allows us to
confirm that the main source of ROS during CAF-mediated
EMT is COX-2 (Fig. 4C). In addition, ROS removal abolishes
the activation of HIF-1a and NF-jB (Supplementary Fig. S4).
In keeping with a key role of ROS as mediators of EMT sig-
naling, we observed that both NAC and catalase are able to
inhibit achievement of stem cell traits in PC3 cells. Indeed,
ROS removal greatly impairs CD133 and CD44/CD24 ratio
increase due to CAF contact, confirming a role for ROS in
EMT-related stemness (Fig. 4D, E and Supplementary Fig.
S3C, D).
Besides superoxide, COX-2 also produces prostaglandins
(34). We observed that in PC3 cells, after block of COX-2 with
nimesulide, the administration of prostaglandin E2 (PGE2)
does not imitate CAF exposure. Indeed, CAFs or in vitro
activated HPFs are ineffective on PC3 cells treated with ni-
mesulide and PGE2, which are unable to activate COX-2,
HIF-1, and the EMT transcriptional program (Supplemen-
tary Fig. S5A, B). Conversely PGE2 is partly active on NF-jB
activation.
CAF-mediated proinflammatory signals enhance tumor
formation and metastasis dissemination
To demonstrate that CAF-induced pro-oxidant and
inflammatory activation of COX-2/HIF-1 axis is a neces-
sary requirement for tumor growth and metastatic spread,
we subcutaneously injected in SCID mice a mixture of CAFs
and PC3 cells. We have already reported that 1 · 106 PC3
cells and absence of Matrigel are limiting conditions in
which CAFs exert their spur for both xenografts and
spontaneous metastases (17). The results indicate that
silencing of COX-2 or HIF-1a in PC3 cells completely abol-
ishes the effects exerted by CAFs on xenografts (Fig. 5A).
CAFs co-injectedwith PC3 cells silenced for COX-2 orHIF-1a
do not give rise to tumors even at the end point (92 days).
In keeping with our previous observations, we detect
spontaneous lung metastases in mice injected with PC3 +
CAFs (Fig. 5A).
To confirm the involvement of the pro-oxidant and in-
flammatory COX-2/HIF-1 pathway in metastatic spread of
EMT undergoing cells, we carried out an experimental me-
tastasis assay. This assay assesses the ability of tumor cells to
survive in the bloodstream, to extravasate, and to address the
tumor in a new location. Our experimental design is based on
in vitromimic of CAF/PC3 contact and EMT engagement and
in vivo analysis of lung colonization of conditioned PC3 cells.
FIG. 2. CAFs promote a
COX-2-dependent oxidative
response. (A) PC3cells were in-
cubated with the indicated CM,
in the presence or not of antioxi-
dant compounds (for 24h): 1lg/
ml catalase as a general H2O2
scavenger, 5lM DPI specific for
NADPH oxidase, 10lM NDGA
for 5¢-lipoxigenase, 10lM ASA
forCOX-1andCOX-2, and75lM
Nimesulide selective for COX-2.
H2O2 production was evaluated
by means of H2DCF-DA incuba-
tion and spectrophotometric
analysis, normalized on total
protein content, and plotted.
*p<0.001 versus CAFs. (B) PC3
cellswere treated as inA, and cell
invasion was evaluated. Invad-
ing cells were counted, photo-
graphed, and a bar graph,
representative of six randomly
chosen fields, is shown. *p<0.005
versus CAFs. (C) PC3cells stably
silenced with shRNA for COX-2,
or with negative control shRNA,
were incubated with CM, and
H2O2 production was evalu-
ated as in A. *p<0.001 versus
Ctrl HPFs+TGFb1, HPFs+ IL-6,
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We checked that PC3 cells, after in vitro contact with CAFs,
have undergone EMT and activation of COX-2 andHIF-1 (Fig.
5B). The results reveal that CAF-conditioned cells give rise to a
25-fold increase in formation of lung metastatic nodules (Fig.
5C). In keeping, silencing of COX-2 or HIF-1a dramatically
reduces the effect of CAFs on formation of lung metastases,
thereby confirming that the spur elicited by CAFs through
induction of EMT, which gives rise to a highly aggressive
phenotype in PC3 cells able to successfully colonize distant
organs with metastatic tumors, is greatly dependent on the
activation of proinflammatory signaling through COX-2 and
HIF-1 by CAFs.
FIG. 3. Metalloprotease and Rac1
inhibition strongly impairs the
proinflammatory response and
EMT. (A) PC3 cells were incubated
with the indicated CM in the pres-
ence or not of ilomastat (50 lM) for
24 h. The levels of COX-2, HIF-1a,
and IkBa were assessed by immu-
noblotting. (B) Cells were treated as
in A, and H2O2 production was
evaluated by means of H2DCF-DA,
normalized on total protein con-
tent, and plotted. *p< 0.001 versus
Ctrl HPFs + IL-6 and CAFs, respec-
tively. (C) Cells were treated as just
stated, and the expression of EMT
markers was analyzed by immu-
noblotting. (D) PC3 cells were
treated with the corresponding
CM. The amount of active Rac1-
GTP was assessed by pull-down
assay, and the total amount of Rac1
was quantified by anti-Rac1 im-
munoblotting (upper panel). Rac1b
expression was evaluated by anti-
Rac1b immunoblotting (lower pan-
el). (E) PC3 cells were treated as in
D, and Rac1b activity was evalu-
ated by a pull down assay. The
total amount of Rac1b was also
quantified by anti-Rac1b immunoblot. (F) Cells were treated as in D, with or without Rac1
inhibitor administration (90 lM). The levels of COX-2, HIF-1a, and IkBa were assessed by
immunoblotting (upper panel). Impairment of Rac1 activation on Rac1 inhibitor treatment was
confirmed by a pull down assay (lower panel).
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Discussion
The results presented in this report lead to three major con-
clusions: (i) CAFs act on cancer cells by activating a proin-
flammatory route, thus leading them to achieve a motile and
stem-like phenotype through EMT; (ii) the proinflammatory
signature activated in cancer cells is mainly driven by the
pathway involving NF-jB, COX-2, and HIF-1; and (iii) in re-
sponse to CAF contact, cancer cells experience a COX-2-medi-
ated ROS delivery, driven by MMP-activated Rac1b, which is
mandatory for EMT and dissemination of metastatic cells.
Inflammation has already been correlated with EMT acti-
vation. For example, administration of tumor necrosis factor-a
is able to stabilize Snail-1, a known transcription factor lead-
ing to EMT, through inhibition of its ubiquitination and
degradation (46). CAF-mediated proinflammatory signals
appear to be mainly mediated by MMPs released directly by
activated fibroblasts, as indicated by sensitivity of EMT acti-
vation to ilomastat, a broad-range inhibitor of MMPs (17).
Although we have reported that CAFs secrete mainly MMP-2
and MMP-9, both of them able to cleave E-cadherin and to
elicit EMT in several cancer models (21), further analyses are
warranted for the identification of the protease/s specifically
involved.
We now involve NK-kB and HIF-1 transcription factors as
key players for CAF-mediated EMT activation. NF-jB has
already been shown to negatively control the Snail-1 tran-
scription factor ubiquitination and degradation through
regulation of COP9 signalosome 2 in response to tumor ne-
crosis factor-a (45). Besides, HIF-1 has been correlated with
the EMT process through the activation of both Twist and
Snail-1 transcription factors, leading to increased in-
vasivenss (6, 47). We report herein an activation of HIF-1 in
response to CAF contact in normoxic conditions, which is
mandatory for in vitro EMT activation as well as for both
xenograft and lung metastasis formation. In keeping with
our findings, activation of HIF-1 has been reported also in
normoxic conditions, as treatment with several GFs and
chemo-attractive agents (5, 38). Interestingly, EMT activa-
tion and chemotaxis surely share the activation of a migra-
tory cell behavior, therefore allowing a correlation of
non-hypoxic activation of HIF-1 to the induction of a mi-
gratory behavior for PCa cells.
We also engage COX-2 expression, as well as its produc-
tion of ROS, in the activation of EMT by CAFs. COX-2 is
dramatically known as a conspirator of prostate cancer
progression, although its specific role is uncertain. Early
observations indicated a correlation with expression of
FIG. 4. CAF-induced oxida-
tive stress is mandatory to
elicit EMT and stemness. (A)
PC3 cells were treated with the
indicated CM in the presence
or not of catalase (1lg/ml) for
24h. Cell invasion was evalu-
ated by Boyden assay. Invad-
ing cells were counted,
photographed, and a bar
graph, representative of six
randomly chosen fields, is
shown. *p< 0.001 versus Con-
trol HPFs+TGFb1, HPFs+ IL-
6, and CAFs, respectively. (B)
PC3 cells treated as in A were
checked for the expression of
EMT markers. (C) PC3cells
were incubated with CM from
HPFs or from CAFs with or
without antioxidant adminis-
tration for 24h: 10lM NDGA,
1lg/ml catalase, 5lM DPI,
10lM ASA, and 75lM Ni-
mesulide. The expression of
EMT markers was evaluated
by immunoblotting. (D, E)
PC3 cells were treated as in A,
and the percentage of CD133
positive cells (D) and
CD44high/CD24low cells (E)
was analyzed by means of
FACS analysis. *p< 0.001 ver-
sus Control HPFs+TGFb1,
HPFs+ IL-6, and CAFs, re-
spectively.
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COX-2 and prostate tumor grade (19, 23, 34). In addition,
COX-2 has also found increased in high-grade prostate
intraepithelial neoplasia in the TRAMP mouse model (37).
Interestingly, selective COX-2 inhibitors induce apoptosis
in PC3 cells grown in nude mice (24). Conversely, few
data correlate COX-2 expression with an invasive/motile
phenotype, reminiscent of the EMT process induced by
CAFs we are reporting herein. Forced COX-2 overexpression
contributes to malignant phenotype by decreased E-
cadherin expression and by modulated production of
angiogenic factors (44, 48). Between the two products of
COX-2, that is, prostaglandins and ROS, our data indicate
ROS as the major factor responsible for the activation of the
EMT programme. Indeed, PGE2 administration is not able to
rescue the complete block of EMT of PC3 cells induced by
COX-2 inhibition. In keeping with a key role of COX-2-
mediated ROS delivery, both antioxidant treatment and
COX-2/inhibition/silencing totally impedes engagement of
the EMT programme.
ROS can act on tumor progression in several ways. They
cause oxidative damage to DNA and genomic instability or
alter gene expression through modulation of transcription
factors. In addition, repeated treatment with H2O2 caused a
phenotypic conversion from mammary epithelial to fibro-
blast-like as in malignant transformation (27). In mammary
carcinoma cells, ROS have also been correlated with EMT,
FIG. 5. CAF-induced proin-
flammatory response pro-
motes tumor formation and
lung metastatic colonization.
(A) Xenograft growth in SCID
bg/bg mice. Stably silenced
PC3 cells with shRNA for
COX-2, shRNA HIF-1a, or
with negative control shRNA
were subcutaneously injected
in both the lateral flanks of
mice with or without CAFs.
Tumor latency, growth rate,
and incidence are reported
in the table. Representative
paraffin-embedded tissue sec-
tions from primary tumour
(a) and lung micrometastases
(b) obtained by subcutaneous
injection of PC3 cells and
CAFs, stained with hematox-
ylin and eosin, are shown.
Bar 50 lM. aTime between
tumor cell injection and de-
tection of a palpable tumor in
50% of mice. bNumber of
mice with tumor/number of
inoculated mice. cNot de-
tected at 3 months from in-
jection of tumor cells. (B)
Stably silenced PC3 cells with
shRNA for COX-2, shRNA
HIF-1a, or with negative
control shRNA were treated
with CM from CAFs. The real
EMT of PC3 cells treated with
CM was confirmed by ex-
pression of EMT markers,
and the immunoblots for E-
Cad and Met were shown.
Silencing of COX-2 and HIF-
1a was confirmed by immu-
noblotting. (C) PC3 cells de-
scribed in B were injected
into the lateral tail vein of
SCID bg/bg mice. After 8
weeks, the animals were sac-
rificed, and the lungs were
examined. Lung nodules
were counted, and the median values – standard deviation are shown in the table. Lungs obtained by CAF-treated PC3,
which show a higher number of surface lung colonies, are shown (a, b).
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through a Rac1b-mediated delivery of mitochondrial ROS
(36). In keeping with these findings, CAF-mediated EMT
also involves Rac1b expression/activation. Rac1 is a key
player of mesenchymal motility, as it drives cell polariza-
tion, leading to edge organization and lamellipodia for-
mation (33). The Rac1b isoform is constitutively activated,
but its specific role is still unknown. Its involvement in
mammary carcinoma EMT has been correlated with mito-
chondrial ROS delivery, whereas CAF-mediated EMT
of PCa cells exploits ROS produced by COX-2 activity,
thereby suggesting that different ROS sources can be used
for the same plan. Noteworthy, although CAF-induced
EMT of PC3 cells is clearly MMP- and Rac1b-dependent,
some differences emerge from in vitro activation of HPFs.
Indeed, although IL-6 induces an activation state in HPFs
very similar to CAFs extracted from patients bearing
PCas (17), TGF-b1-treated HPFs, commonly referred to as
myofibroblasts (17, 21), affect PC3 EMT in an MMP/Rac1b-
independent manner. These findings are in agreement
with previous observations showing activation of Rac1b
in MMP3-dependent EMT of breast carcinoma cells, but
not in cells undergoing TGF-b1-dependent EMT (28).
In addition, we underline that, although Radisky et al.
supported ROS as carcinogenic agents acting on genomic
instability and classifying their redox-mediated EMT of
cancer cells as a source for cancer associated myofibro-
blasts (36), our data implicate ROS as key mediators of
tumor progression, through achievement of a motile and
stem-like behaviour, leading cancer cells to spread to
distant organs.
HIF-1 transcription factor is a major candidate as target
for ROS produced during CAF-induced EMT. Indeed, HIF-
1 is stabilized by a redox-dependent pathway, involving
inactivation of prolyl hydroxylases, iron-dependent en-
zymes engaged in degradation of HIFs (20, 32). The key
role of redox stabilization of HIF-1 has also been under-
scored by recent data describing that the antitumorigenic
effects of NAC and VitC depend on HIF-1 redox stabili-
zation (16). In a model of mouse breast cancer, a recent
article also implicated oxidative stress, due to JunD dele-
tion, as the driving force for myofibroblasts differentiation.
Again, HIF-1 stabilization due to oxidative stress has been
called on for activation of fibroblasts into myofibroblasts,
cytokine secretion, and tumor spread (42). We now involve
a redox-mediated HIF-1 accumulation for activation of
EMT in prostate cancer cells, allowing them to escape the
primary tumor and disseminate metastases. In keeping
with our observations, early EMT-related events induced
by hypoxia, as regulation of glycogen synthase kinase-3b
and Snail-1, were dependent on transient intracellular
generation of ROS (6).
The final picture of the interplay between CAFs and tu-
mors during cancer progression involves ROS at least at two
key levels: (i) fibroblasts may exploit oxidative stress for
their activation and for affecting tumor aggressiveness,
macrophage recruitment, and angiogenesis (7, 13, 42), (ii)
CAF-induced EMT of PCa cells is again redox dependent for
allowing achievement of mesenchymal motility and escap-
ing the invasive front of tumors. Both processes exploit
similar proinflammatory oxidative molecular signature, in-
volving NF-jB, COX-2, and HIF-1. Considering that metas-
tasis is a phenomenon reminiscent of themigratory/invasive
behavior of inflammatory cells, it is not surprising that CAF-
mediated EMT undergoing cells share with inflammatory
cells the same signals. Indeed, both metastatic and inflam-
matory cells need to move away, invade/infiltrate the local
sites where they are recruited by appropriate signals. Hence,
we can propose a new challenge to the paradigm of antiox-
idants as valuable antimetastatic therapeutic tools, as they
can affect both stromal cell reactivity (42) and cancer cells
malignancy.
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